New conditioning regimen with idarubicin and melphalan in autologous PBPC transplantation

被引：0
|
作者：
Musso, M
Porretto, F
Crescimanno, A
Bondi, F
Polizzi, V
Scalone, R
Cajozzo, A
Mariani, G
机构：
[1] Univ Palermo, Cattedra Ematol TMO, I-90133 Palermo, Italy
[2] Univ Palermo, Div Ematol TMO, I-90133 Palermo, Italy
来源：
BONE MARROW TRANSPLANTATION | 1998年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
342
引用
收藏
页码：S97 / S97
页数：1
相关论文
共 50 条
  • [31] HIGH-DOSE BUSULFAN AND MELPHALAN AS CONDITIONING REGIMEN PRIOR TO TRANSPLANTATION
    MARIT, G
    CONY, P
    DAVID, B
    BROUSTET, A
    REIFFERS, J
    BONE MARROW TRANSPLANTATION, 1988, 3 : 78 - 78
  • [32] Selinexor in Combination with Standard or Reduced-Dose Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Multiple Myeloma
    Shuai, Su
    Xu, Bin
    Li, Chunrui
    Wang, Di
    Tong, Xiwen
    Zhu, Yi
    Mao, Xia
    Xiao, Min
    Zhang, Donghua
    BLOOD, 2024, 144 : 7062 - 7063
  • [33] Busulfan, Melphalan, and Bortezomib Compared to Single Agent High-Dose Melphalan As a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma: Long Term Follow up of a Novel Conditioning Regimen
    Hagen, Patrick
    D'Souza, Anita
    Hari, Parameswaran
    Davila, Omar
    Zhang, Mei-Jie
    Vesole, David H.
    Smith, Scott E.
    Rodriguez, Tulio E.
    Stiff, Patrick J.
    BLOOD, 2019, 134
  • [34] Efficacy and toxicity of SEAM (semustine, etoposide, cytarabine, and melphalan) conditioning regimen followed by autologous stem cell transplantation in lymphoma
    Zhang, Lihong
    Yang, Haifei
    Qian, Chongsheng
    Zhou, Jihao
    Zhu, Qian
    Jiang, Yibin
    Liu, Shuo
    Chen, Xiaochen
    Xu, Ting
    Qu, Changju
    Li, Caixia
    Jin, Zhengming
    Chu, Jianhong
    Zhang, Xinyou
    Wu, Depei
    Huang, Haiwen
    HEMATOLOGY, 2022, 27 (01) : 404 - 411
  • [35] The effectiveness of the conditioning regimen high dose melphalan with bortezomib with autologous transplantation of hematopoietic stem cells in patients with multiple myeloma
    Khorobrykh, Marina
    Zorina, Natalia
    Minaeva, Natalia
    Sherstnev, Philipp
    Paramonov, Igor
    BONE MARROW TRANSPLANTATION, 2018, 53 : 293 - 294
  • [36] Mitoxantrone and melphalan conditioning regimen for autologous peripheral blood stem cell transplantation in adults with acute myelogenous leukemia.
    Sprague, K
    Padgaonkar, V
    Klein, AK
    Chan, GW
    Miller, KB
    Klingemann, H
    BLOOD, 2005, 106 (11) : 466B - 466B
  • [37] BUSULFAN AND MELPHALAN AS CONDITIONING REGIMEN FOR AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA
    ALEGRE, A
    LAMANA, M
    ARRANZ, R
    FERNANDEZVILLALTA, MJ
    TOMAS, JF
    FIGUERA, A
    CAMARA, R
    STEEGMAN, JL
    CASADO, F
    REQUENA, MJ
    PLANAS, JL
    VAZQUEZ, L
    GRANDA, A
    FERNANDEZRANADA, JM
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 91 (02) : 380 - 386
  • [38] TEAM (THIOTEPA, ETOPOSIDE, CYTARABINE, MELPHALAN) AS CONDITIONING REGIMEN FOR LYMPHOMA TREATMENT WITH AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION (AHSCT)
    Carella, A. M.
    Palumbo, G.
    Merla, E.
    Greco, M.
    Fontana, A.
    Specchia, G.
    Pisapia, G.
    Mazza, P.
    Guarini, A.
    Rana, A.
    Ditonno, P.
    Ferrara, F.
    Musto, P.
    Pastore, D.
    Scime, R.
    Pellegrini, F.
    Capalbo, S.
    Cavallaro, A. Maria
    Cascavilla, N.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S177 - S177
  • [39] A novel conditioning regimen or thiotepa, melphalan, and cyclophosphamide for autologous stem cell transplantation (ASCT) in chemosensitive multiple myeloma.
    Venigalla, M
    Azar, D
    Becker, P
    Emmons, R
    Westervelt, P
    Hsieh, CC
    Qin, L
    Ballen, K
    BLOOD, 2002, 100 (11) : 436A - 436A
  • [40] Melphalan and total-body irradiation as a conditioning regimen for autologous bone marrow transplantation in acute myeloid leukemia.
    Treleaven, J
    Powles, R
    Singhal, S
    Horton, C
    Tait, D
    Meller, S
    Pinkerton, CR
    Mehta, J
    BLOOD, 1995, 86 (10) : 3861 - 3861
12345